ANEBULO PHARMACEUTICALS, INC.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2021 | $241.6K | $21.7M | — |
| FY2022 | $512.5K | $15.6M | — |
| FY2023 | $1.1M | $11.7M | $11.2M |
| FY2024 | $260.6K | $4.1M | $3.1M |
| FY2025 | $487.7K | $12.1M | $11.6M |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2021 | $241.6K | $21.7M | — |
| FY2022 | $512.5K | $15.6M | — |
| FY2023 | $1.1M | $11.7M | $11.2M |
| FY2024 | $260.6K | $4.1M | $3.1M |
| FY2025 | $487.7K | $12.1M | $11.6M |